Home  »  Industry   »  ROIV’s 52-Week Rollercoaster: From $2.87 to ...

ROIV’s 52-Week Rollercoaster: From $2.87 to $12.84 – What’s Next for Investors?

Roivant Sciences Ltd. (ROIV) current stock price is $11.29. During the last trading session, the stock soared, reaching $11.57 after opening at $11.49. The stock’s lowest point was $11.22 before it closed at $11.49.

Roivant Sciences Ltd. had a pretty favorable run when it comes to the market performance. Over the past year, the company’s stock reached a high of $12.84 on 09/11/23, while the lowest price during the same period was $2.87 on 09/23/22.

Do You Know The Best Place To Find Gains In Volatile Markets?

In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.

Click here for full details and to join for free

52-week price history of ROIV Stock

A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Roivant Sciences Ltd.’s current trading price is -12.07% away from its 52-week high, while its distance from the 52-week low is 293.38%. The stock’s price range during this period has fluctuated between $2.87 and $12.84. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 22.38 million for the day, which was evidently higher than the average daily volume of 5.12 million over the last three months.

Financial Performance and Market Capitalization

Roivant Sciences Ltd. (ROIV) has experienced a quarterly rise of 13.81% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 8.87B and boasts a workforce of 904 employees.

Analysts’ Ratings For Roivant Sciences Ltd.

As of right now, 7 analysts are rating Roivant Sciences Ltd. as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 10.35, with a change in price of +2.42. Similarly, Roivant Sciences Ltd. recorded 4,446,913 in trading volume during the last 100 days, posting a change of +27.28%.

ROIV Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ROIV stands at 0.47. Similarly, the long-term debt-to-equity ratio is also 0.42.

ROIV Stock Stochastic Average

The raw stochastic average for Roivant Sciences Ltd. over the last 50 days is presently at 40.38%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 40.38%. Further, the company’s Stochastic %K and %D values for the last 20 days were 41.28% and 40.77%, respectively.

ROIV Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. Until today this year the stock’s price performance recorded an increase of 41.30%. However, over the last six months, the performance has been weaker by 32.82%. The price of ROIV increased 4.44% over the last 30 days. And in the last five days, it has fallen by -10.40%.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts